期刊名称：INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims and scope
The International Journal for Peptide Research & Therapeutics is an international, peer-reviewed journal focusing on issues, research, and integration of knowledge on the latest developments in peptide therapeutics. The Journal brings together in a single source the most exciting work in peptide research, including isolation, structural characterization, synthesis and biological activity of peptides, and thereby aids in the development of unifying concepts from diverse perspectives. The Journal invites substantial contributions in the following thematic areas: -New advances in peptide drug delivery systems.
-Application of peptide therapeutics to specific diseases.
-New advances in synthetic methods.
-The development of new procedures for construction of peptide libraries and methodology for screening of such mixtures.
-The use of peptides in the study of enzyme specificity and mechanism, receptor binding and antibody/antigen interactions
-Applications of such techniques as chromatography, electrophoresis, NMR and X-ray crystallography, mass spectrometry.
Instructions to Authors
Instructions for Authors
International Journal of Peptide Research and Therapeutics
Types of Manuscripts
Review articles, original articles, short communications, letters to the Editor and book reviews will be considered for publication. Please contact the Publisher for full details.
Online Manuscript Submission
Springer offers authors, editors and reviewers of IJPRT the use of our fully web-enabled online manuscript submission and review system. To keep the review time as short as possible, we request authors to submit manuscripts online to the journal's editorial office. Our online manuscript submission and review system offers authors the option to track the progress of the review process of manuscripts in real time. Manuscripts should be submitted to:http://IJPR.edmgr.comThe online manuscript submission and review system for IJPRT offers easy and straightforward log-in and submission procedures. This system supports a wide range of submission file formats: for manuscripts - Word, WordPerfect, RTF, TXT, and LaTex; for figures - TIFF, GIF, JPEG, EPS, PPT, and Postscript. PDF is not an acceptable format.NOTE: In case you encounter any difficulties while submitting your manuscript online, please get in touch with the responsible Editorial Assistant by clicking on "CONTACT US" from the tool bar.Authors are requested to download the Consent to Publish and Transfer of Copyright form from the journal's website. Please send a completed and duly signed form either by mail or fax to the Editorial Office of IJPRT. Authors should still follow the regular instructions for authors when preparing their manuscripts (see below).International Journal of Peptide Research and TherapeuticsNina BenninkSpringerEditorial OfficePO Box 173300 AA DordrechtThe Netherlandsnina.bennink@springer.com*Please do not send manuscripts to this address.
Style of Manuscripits
Manuscripts should be typed with double spacing on standard size paper. Spelling should conform to Webster’s International Dictionary and System International (SI) units should be used throughout. Abbreviations should be kept to a minimum and be defined at first mention. Generic names should be used for drugs (brand names may be inserted in parentheses). The title page should include a concise and descriptive title for the paper, the full name(s) of the author(s); the institutional affiliation of each author; the name and address of the corresponding author (including e-mail address, telephone and fax numbers); an abbreviated title; and any acknowledgment of financial or material support. This should be followed by the abstract page, summarizing in bold font 12, no more than 250 words the reason for the study, the major finding (with specific data if possible), and the principal conclusions, and providing 3-6 key words for indexing purposes. Emphasis of headings should follow these font styles: Introduction, font 14 bold; subheading, font 12 bold, and sub-heading, font 12 italics. The text of the report should then proceed as follows:
|
Introduction. Describe the background of the investigation, citing only essential references, and state the aim(s) of the study. |
|
Materials and Methods. Give sufficient detail for future repetition. Describe new methods in detail; providing references and brief descriptions for previously published methods. Research on human subjects should indicate that ethical approval was obtained. |
|
Results and Discussion. Present data in a single form. Emphasis should be on clear and precise presentation of results and their significance in relation to the aim of the investigation. Review the results of the study in the light of previously published work. |
|
Concluding Remarks. Give a brief conclusion of less than 200 words. |
|
Acknowledgments. Detail contributions, including technical help or other assistance, requiring acknowledgment but not justifying authorship in less than 50 words. |
|
References. References should appear alphabetically. The reference list must be double spaced and should include: names and initials of all authors when there are six or fewer (when there are more than six authors, list the only first three followed by et al.), full title of the article, journal title abbreviated according to Index Medicus, year, volume number and page span. For reference cited from books, the chapter title should be followed by the names and initials of the editors, the book title, edition, place of publication, publisher, year and page span. | References are to appear in Harvard style in text:Jones (2003) or (Jones, 2003)Jones and Smith (2004) or (Jones and Smith, 2004)Jones et al. (2004), Jones and colleagues (2004) or (Jones et al., 2004)Multiple ones separated by a ??/SPAN>
|
Paper: Oliver, S.G., Winson, M.K., Kell, D.B. and Baganz, F. (1998) Systematic functional analysis of the yeast genome. Trends Biotechnol. 16, 373-378. |
|
Book: Jolliffe, I.T. (1986). Principal Component Analysis. Springer-Verlag, New York. |
|
Chapter in Book: Beecher, C.W.W. (2003). The human metabolome in Harrigan, G.G. and Goodacre, R. (Eds), Metabolomic profiling: its role in biomarker discovery and gene function analysis. Kluwer Academic Publishers, Boston, pp. 311-319. |
Only accepted papers should be referenced; all other material should be referred to in the text as "in preparation" "personal communication"or "unpublished observations"and should not be included in the reference list (see also Permissions). Authors are responsible for the accuracy of their references.
Style for Illustrations
All tables and illustrations must be numbered and referred to in the text, with appropriate locations indicated in the text margin. Tables should be typed with double spacing with a descriptive title and, if appropriate, units of numerical measurements included in the column heading. All lettering should be large enough to permit legible reduction. Axes should be labeled clearly; any other lettering should be kept to a minimum. Magnifications should be shown with scale bars. Color illustrations are acceptable, but authors will be expected to cover the extra reproduction costs: $1150 per article. Suggested figure formats: TIFF, GIF, EPS, PPT, and Postscript. Files should be at least 300 dpi.
Conflict of Interest
Authors should disclose any commercial or other associations that might pose a conflict of interest in connection with the submitted article.
Permissions
Materials copied from other sources must be accompanied by a written statement from both author and publishers, giving permission for reproduction. Permission in writing should also be obtained for citations of unpublished data, personal communications, and papers still in press. Authors are themselves responsible for obtaining permission to reproduce copyright material from other sources.
Proofing
Please be sure to include your e-mail address on your paper. If your paper is accepted, we will provide proofs electronically. Your cooperation is appreciated. The proofread copy should be returned to the Publisher within 72 hours.
Copyright
It is the policy of Springer to own the copyright of all contributions it publishes. To comply with U.S. Copyright Law, authors are required to sign a copyright transfer form before publication. This form returns to authors and their employers full rights to reuse their material for their own purposes. Authors must submit a signed copy of this form with their manuscript.
Appendices and Supplementary Material
Authors who wish to publish electronic supplementary material to their article (Excel files, images, audio/video files) are requested to submit their manuscript via our online submission system, with a note in the author comments box that supplementary material will be submitted separately by email. This email, containing the supplementary material, should be sent to the Production Editor. In the email, the title of the submitted manuscript as well as the name of the corresponding author should be given.
Springer Open Choice
In addition to the normal publication process (whereby an article is submitted to the journal and access to that article is granted to customers who have purchased a subscription), Springer now provides an alternative publishing option: Springer Open Choice. A Springer Open Choice article receives all the benefits of a regular subscription−based article, but in addition is made available publicly through Springers online platform SpringerLink. To publish via Springer Open Choice, upon acceptance please click on the link below to complete the relevant order form and provide the required payment information. Payment must be received in full before publication or articles will publish as regular subscription−model articles. We regret that Springer Open Choice cannot be ordered for published articles.
Editorial Board
Editorial Board
Editors-in-Chief
Fernando Albericio, Institut de Recerca Biomedica, Barcelona, Spain
Gregg B. Fields, Florida Atlantic University, Boca Raton, Florida, USA
John D. Wade, Howard Florey Institute, Melbourne, Victoria, Australia
Editorial Board
Mibel Aguilar, Monash University, Clayton, Victoria, Australia
Saburo Aimoto, Osaka University, Institute For Protein Research, Suita, Osaka, Japan
Jane Aldrich, University of Kansas, Lawrence, Kansas, USA
Paul Alewood, Institute of Molecular Bioscience, Brisbane, Queensland, Australia
David Andreu, Pompeu Fabra University, Barcelona, Spain
George Barany, University of Minnesota, Minneapolis, Minnesota, USA
Ettore Benedetti, Universita di Napoli, Naples, Italy
Louis A. Carpino, University of Massachusetts, Amherst, Massachussets, USA
Waleed Danho, Hoffmann-La Roche Inc., Nutley, New Jersey, USA
Phillip E. Dawson, The Scripps Research Institute, La Jolla, California, USA
Illana Gozes, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel
Ronald Frank, Department of Chemical Biology, GBF, Braunschweig, Germany
Matityahu Mati Fridkin, Weizmann Institute Of Science, Rehovot, Israel
Carlos Garcia-Echeverria, Novartis Institute for Biomedical Research, Basel, Switzerland
Satish Joshi, Peptisyntha, Inc., Torrance, California, USA
Steven A. Kates, Ceremedix, Inc., Worcester, Massachussets, USA
Pravin TP Kaumaya, Ohio State University ?College of Medicine & Public Health, Columbus, Ohio, USA
Jeffrey W. Kelly, The Scripps Research Institute, La Jolla, California, USA
György Kéri, Semmelweis University, Budapest, Hungary Ulo Langel, Stockholm University, Stockholm, Sweden
Yoon-Sik Lee, Seoul National University, Seoul, Korea
Keliang Liu, Beijing Institute of Pharmacology & Toxicology, Beijing, China
Jean Martinez, University of Montpellier/CNRS, Montpellier, France
John P. Mayer, Eli Lilly & Co., Indianapolis, Indiana, USA
Dewey G. McCafferty, Duke University, Durham, North Carolina, USA
Laszlo Otvos, Jr., Temple University, Philadelphia, Pennsylvania, USA
Anna Papini, University of Florence, Florence, Italy
Michael Pennington, Bachem Bioscience Inc., King of Prussia, Pennsylvania, USA
Yasutsugu Shimonishi, Nagahama Institute of Bioscience and Technology, Nagahama, Shiga, Japan
Takayuki Shioiri, Graduate School of Environmental & Human Sciences, Meijo University, Tempaku, Nagoya, Japan
A. Ian Smith, Monash University, Clayton, Victoria, Australia
Michael Verlander, PolyPeptide Laboratories, Inc., Torrance, California, USA
Holger Wenschuh, Jerini AG, Berlin, Germany
Samuel Zalipsky, ALZA Corporation, Mountain View, California, USA
|
